Commentary on Zhou et al. (2015): Treating psychiatric comorbidity in adolescents-an important problem

Addiction

Volumn 110, Issue 1, 2015, Pages 49-50

  Nunes, Edward V ^a  

^a NEW YORK STATE PSYCHIATRIC INSTITUTE   (United States)

Author keywords

ADHD (attention deficit hyperactivity disorder); Adolescence; Antidepressant; Co occurring depression; Medication; Meta analysis; PTSD (post traumatic stress disorder); Substance use disorders, treatment

Indexed keywords

ANTIDEPRESSANT AGENT;

ADOLESCENT; CHILD; COMPLICATION; DEPRESSIVE DISORDER; FEMALE; HUMAN; MALE; PSYCHIATRIC DIAGNOSIS; SUBSTANCE-RELATED DISORDERS; YOUNG ADULT;

ADOLESCENT; ANTIDEPRESSIVE AGENTS; CHILD; DEPRESSIVE DISORDER; DIAGNOSIS, DUAL (PSYCHIATRY); FEMALE; HUMANS; MALE; SUBSTANCE-RELATED DISORDERS; YOUNG ADULT;

EID: 84923175569     PISSN: 09652140     EISSN: 13600443     Source Type: Journal    
DOI: 10.1111/add.12786     Document Type: Note

References (17)

1. Waldron H. B., Turner C. W. Evidence-based psychosocial treatments for adolescent substance abuse. J Clin Child Adolesc Psychol 2008; 37: 238-61.
2. Stanger C., Budney A. J. Contingency management approaches for adolescent substance use disorders. Child Adolesc Psychiatr Clin N Am 2010; 19: 547-62.
3. Zhou X., Qin B., Del Giovane C., Pan J., Gentile S., Liu Y. etal. Efficacy and tolerability of antidepressants in the treatment of adolescents and young adults with depression and substance use disorders: a systematic review and meta-analysis. Addiction 2015; 110: 38-48.
4. Riggs P. D., Mikulich-Gilbertson S. K., Davies R. D., Lohman M., Klein C., Stover S. K. A randomized controlled trial of fluoxetine and cognitive behavioral therapy in adolescents with major depression, behavior problems, and substance use disorders. Arch Pediatr Adolesc Med 2007; 161: 1026-34.
5. Cornelius J. R., Bukstein O. G., Douaihy A. B., Clark D. B., Chung T. A., Daley D. C. etal. Double-blind fluoxetine trial in comorbid MDD-CUD youth and young adults. Drug Alcohol Depend 2010; 112: 39-45.
6. Nunes E. V., Levin F. R. Treatment of depression in patients with alcohol or other drug dependence: a meta-analysis. JAMA 2004; 291: 1887-96.
7. Torrens M., Fonseca F., Mateu G., Farré M. Efficacy of antidepressants in substance use disorders with and without comorbid depression. A systematic review and meta-analysis. Drug Alcohol Depend 2005; 78: 1-22.
8. Hobbs J. D., Kushner M. G., Lee S. S., Reardon S. M., Maurer E. W. Meta-analysis of supplemental treatment for depressive and anxiety disorders in patients being treated for alcohol dependence. Am J Addict 2011; 20: 319-29.
9. Iovieno N., Tedeschini E., Bentley K. H., Evins A. E., Papakostas G. I. Antidepressants for major depressive disorder and dysthymic disorder in patients with comorbid alcohol use disorders: a meta-analysis of placebo-controlled randomized trials. J Clin Psychiatry 2011; 72: 1144-51.
10. Kranzler H. R., Burleson J. A., Brown J., Babor T. F. Fluoxetine treatment seems to reduce the beneficial effects of cognitive-behavioral therapy in type B alcoholics. Alcohol Clin Exp Res 1996; 20: 1534-41.
11. Pettinati H. M., Volpicelli J. R., Kranzler H. R., Luck G., Rukstalis M. R., Cnaan A. Sertraline treatment for alcohol dependence: interactive effects of medication and alcoholic subtype. Alcohol Clin Exp Res 2000; 24: 1041-9.
12. Hasin D. S., Stinson F. S., Ogburn E., Grant B. F. Prevalence, correlates, disability, and comorbidity of DSM-IV alcohol abuse and dependence in the United States: results from the National Epidemiologic Survey on Alcohol and Related Conditions. Arch Gen Psychiatry 2007; 64: 830-42.
13. Geller B., Cooper T. B., Sun K., Zimerman B., Frazier J., Williams M. etal. Double-blind and placebo-controlled study of lithium for adolescent bipolar disorders with secondary substance dependency. J Am Acad Child Adolesc Psychiatry 1998; 37: 171-8.
14. Salloum I. M., Cornelius J. R., Daley D. C., Kirisci L., Himmelhoch J. M., Thase M. E. Efficacy of valproate maintenance in patients with bipolar disorder and alcoholism: a double-blind placebo-controlled study. Arch Gen Psychiatry 2005; 62: 37-45.
15. Hien D. A., Jiang H., Campbell A. N., Hu M. C., Miele G. M., Cohen L. R. etal. Do treatment improvements in PTSD severity affect substance use outcomes? A secondary analysis from a randomized clinical trial in NIDA's Clinical Trials Network. Am J Psychiatry 2010; 167: 95-101.
16. Lauer M. S., D'Agostino R. B. Sr. The randomized registry trial-the next disruptive technology in clinical research? N Engl J Med 2013; 369: 1579-81.
17. Gelijns A. C., Gabriel S. E. Looking beyond translation-integrating clinical research with medical practice. N Engl J Med 2012; 366: 1659-61.